Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca CEO to step down as Q1 profit falls 44 pct; generics cut into Seroquel sales
AstraZeneca CEO to step down as Q1 profit falls 44 pct; generics cut into Seroquel sales
AstraZeneca CEO to step down as Q1 profit falls 44 pct; generics cut into Seroquel sales
Submitted by
admin
on April 26, 2012 - 9:28am
Source:
Yahoo/AP
News Tags:
David Brennan
earnings
AstraZeneca
Headline:
AstraZeneca CEO to step down as Q1 profit falls 44 pct; generics cut into Seroquel sales
Do Not Allow Advertisers to Use My Personal information
